Evidence map›Paper›PMID 41275117›Full record

ArticleMolecular medicine (Cambridge, Mass.)2025

Sensitivity of RSV detection by PCR in respiratory samples is not reduced by a 24 h delay from sampling to testing with storage at room temperature.

Katie Lihou, Serena McGuinness, Begonia Morales-Aza, Elizabeth Begier, Kaltun Duale, Rosa Aldridge, Nellie Farhoudi, Jonathan Vowles, Dylan Thomas, Jo Southern and 8 more

Abstract read
In one paragraph

Article in Molecular medicine (Cambridge, Mass.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Katie LihouBristol Vaccine Centre, Schools of Population Health Sciences & Cellular and Molecular Medicine, University of Bristol, St Michael's Hill, Bristol, BS2 8AE, UK.
Serena McGuinnessBristol Vaccine Centre, Schools of Population Health Sciences & Cellular and Molecular Medicine, University of Bristol, St Michael's Hill, Bristol, BS2 8AE, UK.
Begonia Morales-AzaBristol Vaccine Centre, Schools of Population Health Sciences & Cellular and Molecular Medicine, University of Bristol, St Michael's Hill, Bristol, BS2 8AE, UK.
Elizabeth BegierGlobal Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, PA, USA.
Kaltun DualeBristol Vaccine Centre, Schools of Population Health Sciences & Cellular and Molecular Medicine, University of Bristol, St Michael's Hill, Bristol, BS2 8AE, UK.
Rosa AldridgeBristol Vaccine Centre, Schools of Population Health Sciences & Cellular and Molecular Medicine, University of Bristol, St Michael's Hill, Bristol, BS2 8AE, UK.
Nellie FarhoudiBristol Vaccine Centre, Schools of Population Health Sciences & Cellular and Molecular Medicine, University of Bristol, St Michael's Hill, Bristol, BS2 8AE, UK.
Jonathan VowlesBristol Vaccine Centre, Schools of Population Health Sciences & Cellular and Molecular Medicine, University of Bristol, St Michael's Hill, Bristol, BS2 8AE, UK.
Dylan ThomasBristol Vaccine Centre, Schools of Population Health Sciences & Cellular and Molecular Medicine, University of Bristol, St Michael's Hill, Bristol, BS2 8AE, UK.
Jo SouthernMedical Evidence Generation, Pfizer Inc, Collegeville, PA, USA.
Jennifer OliverBristol Vaccine Centre, Schools of Population Health Sciences & Cellular and Molecular Medicine, University of Bristol, St Michael's Hill, Bristol, BS2 8AE, UK.
Maria LahuertaGlobal Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, PA, USA.
Kathy SchneiderGlobal Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, PA, USA.
Bradford D GessnerGlobal Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, PA, USA.
Adam FinnBristol Vaccine Centre, Schools of Population Health Sciences & Cellular and Molecular Medicine, University of Bristol, St Michael's Hill, Bristol, BS2 8AE, UK.
Leon DanonEngineering Mathematics, University of Bristol, Bristol, UK.
Catherine HyamsBristol Vaccine Centre, Schools of Population Health Sciences & Cellular and Molecular Medicine, University of Bristol, St Michael's Hill, Bristol, BS2 8AE, UK. Catherine.Hyams@bristol.ac.uk.
AvonCAP Research Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Respiratory Syncytial Virus (RSV) is a common cause of severe respiratory tract disease in infants, the elderly and immunocompromised patients. However, there is uncertainty as to how sample handling practices affect performance of tests to detect RSV. The aim of this study was to determine whether RSV RNA remains reliably detectable in nasopharyngeal/oropharyngeal (NP/OP) samples, saliva, and sputum samples over time.Respiratory samples were collected as part of a prospective observational study of acute lower respiratory tract disease (aLRTD) hospitalisations in adults in Bristol (UK). Samples that tested positive by PCR on receipt (0 h), were re-tested at 24 h having been stored at room temperature. We found that all but one of the samples PCR-positive for RSV at 0 h remained positive at 24 h, across all sample types and RSV strains. Ct values for NP/OP and saliva samples were significantly lower at 24 h than at 0 h, suggesting potential low-level viral replication in the samples. These results suggest that RSV tests can provide consistent results after a delay of up to 24 h following sample collection.

Indexed as

Polymerase Chain ReactionRespiratory Syncytial VirusesRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsSpecimen HandlingAdultAgedFemaleHumansMaleMiddle AgedNasopharynxProspective StudiesRNA, ViralSalivaSensitivity and SpecificityRNA, ViralALRTD diagnosisPCRRSV incidenceSample stabilityViral testing

Identifiers

PMID41275117
PMCPMC12750644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.